WP
CERE
Woodline Partners’s Cerevel Therapeutics Holdings, Inc. Common Stock CERE Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-335,500
| Closed | -$13.7M | – | 739 |
|
|
2024
Q2 | $13.7M | Sell |
335,500
-264,501
| -44% | -$10.8M | 0.13% | 210 |
|
|
2024
Q1 | $25.4M | Buy |
600,001
+394,192
| +192% | +$16.7M | 0.23% | 138 |
|
|
2023
Q4 | $8.73M | Sell |
205,809
-270,825
| -57% | -$11.5M | 0.09% | 242 |
|
|
2023
Q3 | $10.4M | Sell |
476,634
-318,285
| -40% | -$6.95M | 0.12% | 218 |
|
|
2023
Q2 | $25.3M | Buy |
794,919
+183,553
| +30% | +$5.84M | 0.3% | 100 |
|
|
2023
Q1 | $14.9M | Buy |
611,366
+146,958
| +32% | +$3.58M | 0.2% | 144 |
|
|
2022
Q4 | $14.6M | Sell |
464,408
-71,977
| -13% | -$2.27M | 0.2% | 151 |
|
|
2022
Q3 | $15.2M | Buy |
536,385
+280,852
| +110% | +$7.94M | 0.21% | 141 |
|
|
2022
Q2 | $6.76M | Sell |
255,533
-106,220
| -29% | -$2.81M | 0.1% | 217 |
|
|
2022
Q1 | $12.7M | Buy |
361,753
+124,427
| +52% | +$4.36M | 0.21% | 151 |
|
|
2021
Q4 | $7.69M | Buy |
237,326
+41,995
| +21% | +$1.36M | 0.11% | 228 |
|
|
2021
Q3 | $5.76M | Buy |
195,331
+51,619
| +36% | +$1.52M | 0.09% | 233 |
|
|
2021
Q2 | $3.68M | Sell |
143,712
-249,198
| -63% | -$6.38M | 0.07% | 264 |
|
|
2021
Q1 | $5.4M | Buy |
+392,910
| New | +$5.4M | 0.12% | 185 |
|